2002-2004年医院喹诺酮类抗菌药应用调查  

Analysis of the Application of Quinolones Antibacterial in our Hospital from 2002 to 2004

作　　者：翁舜章[1] 陈瑞擎[1] 林振礼[1] 余海宣[1] 张云腾[1] 

机构地区：[1]汕头市中心医院,广东汕头515031

出　　处：《药物流行病学杂志》2006年第2期91-93,共3页Chinese Journal of Pharmacoepidemiology

摘　　要：目的:了解本院喹诺酮类抗菌药的使用情况和用药趋势。方法:对汕头市中心医院2002-2004年喹诺酮类药的应用品种、消耗金额、用药频次(DDDs)、日治疗费用(DDC)等进行统计和排序分析。结果:喹诺酮类抗菌药消耗金额和日治疗费用均逐年上升。口服药用量前两位是诺氟沙星和氧氟沙星;注射剂中左氧氟沙星用量增长较大。结论:本院近年来喹诺酮类药使用基本合理,出现多厂家、多品种激烈竞争的应用趋势,临床应用仍需加强宏观管理。Objective： To analyze the application and medication tendency of quinolones antibacterial in our hospital. Method： The kinds of quinolones antibacterial, consumption, dosage, frequency of drug application, daily drug cost were statistically analyzed and ranked in their order. Result： The consumption and daily drug cost increased year by year, the oral norfloxacin and tarivid took the first and second place. The consumption in the first 3 rank was different, the constituent ratio of the consumption of oral medicine in the first 3 rank was gatifloxacin （ 19.52% ）, tarivid （ 14.90% ）, and sparfloxacin （ 14.02% ） and that of injection quinolones antibacterial was aspartic acid lomefloxacin （25.05%）, fleroxacin （25.02%）, and enoxacin （ 19.46% ）. Conclusion： The application of quinolones antibacterial was reasonable but presented a fierce competition by suppliers among varieties. It is necessary to strengthen the macroscopic management in clinical application.

关 键 词：喹诺酮类药 消耗金额 用药频次 日治疗费用 药物利用 

分 类 号：R978.1[医药卫生—药品]